![]() |
|||
|
|
| UPDATE: February 2006 | MW: 443.06 | MF: C18H34N2O6S•ClH |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN -,1260,1990
|
intraperitoneal | guinea pig
lethal dose (50 percent kill): 732 mg/kg
|
N/R
|
BFPHA8 18,131,1979
|
intraperitoneal | mouse
lethal dose (50 percent kill): 750 mg/kg
|
N/R
|
BFPHA8 18,131,1979
|
intravenous | mouse
lethal dose (50 percent kill): 214 mg/kg
|
N/R
|
TXAPA9 6,476,1964
|
intravenous | rat
lethal dose (50 percent kill): 342 mg/kg
|
N/R
|
TXAPA9 6,476,1964
|
oral | dog
lethal dose : >300 mg/kg
|
N/R
|
TXAPA9 6,476,1964
|
oral | monkey
lethal dose : >300 mg/kg
|
N/R
|
TXAPA9 6,476,1964
|
oral | mouse
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN -,1260,1990
|
oral | rat
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN -,1260,1990
|
subcutaneous | mouse
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN -,1260,1990
|
subcutaneous | rat
lethal dose (50 percent kill): 9,778 mg/kg
|
N/R
|
TXAPA9 9,445,1966
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | guinea pig
lowest published toxic dose: 300 mg/kg/3 day- intermittent
|
Gastrointestinal: Hypermotility, diarrhea | Biochemical: Metabolism (intermediary): Histamines (including liberation not immunochemical in origin) Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
BFPHA8 18,131,1979
|
oral | rat
lowest published toxic dose: 109,200 mg/kg/52 week- continuous
|
Kidney, Ureter, and Bladder: Other changes
|
TXAPA9 6,476,1964
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.5 mg/m3, JUN2003
|
| |||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4977 |
Number of Industries 3; Total Number of Facilities 808; Number of Occupations 14; Total Number of Employees Exposed 20,887; Total Number of Female Employees Exposed 10,760 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
BFPHA8
|
Bulletin of the Faculty of Pharmacy (Cairo University). (Faculty of Pharmacy, Cairo Univ.,
Cairo, Egypt) V.1- 1961/62-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
| |